Targeting PGC-1α to control energy homeostasis

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.11, Iss.10, 2007-10, pp. : 1329-1338

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of PGC-1 in the Pathogenesis of Neurodegenerative Disorders

Current Drug Targets, Vol. 11, Iss. 10, 2010-10 ,pp. : 1262-1269

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the ABCB4 gene to control cholesterol homeostasis

By Oude Elferink Ronald PJ Beuers Ulrich

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 10, 2011-10 ,pp. : 1173-1182

Informa Healthcare

Access to resources Recommend Favorite

Epigenetic modulation of PGC-1α activity by GCN5 inhibitors: WO2010007085

By Carradori Simone Secci Daniela Mai Antonello

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 10, 2011-10 ,pp. : 1651-1656

Informa Healthcare

Access to resources Recommend Favorite

Hypocretin/Orexin Neuropeptides: Participation in the Control of Sleep- Wakefulness Cycle and Energy Homeostasis

Current Neuropharmacology, Vol. 7, Iss. 1, 2009-03 ,pp. : 50-59

Bentham Science Publishers

Access to resources Recommend Favorite

A Novel Danshensu-Tetramethylpyrazine Conjugate DT-018 Provides Cardioprotection by Preserving Mitochondrial Function Through the MEF2D/PGC-1α Pathway

Current Pharmaceutical Design, Vol. 23, Iss. 39, 2018-02 ,pp. : 6062-6070

Bentham Science Publishers

Access to resources Recommend Favorite